RxDoctor Payments Data

Janie Knotts

Physician Assistant · Grantsville, WVNPI 1265766430

Payments from drug & device makers

$1,569in general payments, 2019–2025

Across 100 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$394
  • Lilly USA, LLC$247
  • AbbVie$211
  • AstraZeneca$174
  • Abbott$112
  • Amarin Pharma, Inc.$103
  • plus $328 from 11 others

What the payments were for

  • Food & beverage$1,569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,569 in reported general payments places this provider in the 80th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin94$102,523
OzempicSemaglutide63$89,469
EliquisApixaban66$77,739
Tresiba Flextouch U-200Insulin Degludec25$72,741
MounjaroTirzepatide57$62,382
TrulicityDulaglutide39$57,850
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$49,611
RybelsusSemaglutide27$41,913
VascepaIcosapent Ethyl38$32,956
LinzessLinaclotide30$32,704
FarxigaDapagliflozin Propanediol29$31,945
Tresiba Flextouch U-100Insulin Degludec29$26,962
JanuviaSitagliptin Phosphate29$25,560
TradjentaLinagliptin13$19,539
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$15,997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$394$131,38290 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$57$127,627119 claims
Lilly USA, LLCMounjaro, Trulicity$247$120,23196 claims
PfizerEliquis$12$77,73966 claims
GSKTrelegy Ellipta, Breo Ellipta$62$63,27262 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$174$52,76660 claims
AbbVieLinzess$211$32,70430 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Grantsville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →